Loading…

Eye colour and skin pigmentation as significant factors for refractive outcome and residual accommodation in hypermetropic children: a randomized clinical trial using cyclopentolate 1% and tropicamide 1

Purpose To compare the refractive outcome and residual accommodation with respect to various degrees of iris and skin pigmentation in hypermetropic children using 2 drops of cyclopentolate 1% (C + C) or 1 drop of cyclopentolate 1% and 1 drop of tropicamide 1% (C + T). Methods Two hundred fifty‐one h...

Full description

Saved in:
Bibliographic Details
Published in:Acta ophthalmologica (Oxford, England) England), 2022-06, Vol.100 (4), p.454-461
Main Authors: Minderhout, Helena M., Joosse, Maurits V., Grootendorst, Diana C., Schalij‐Delfos, Nicoline E.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4436-9b0f869c35da5b30c65eadafb954d7e2b93d22fb774bb7b9fe65cf5c65df4c2e3
cites cdi_FETCH-LOGICAL-c4436-9b0f869c35da5b30c65eadafb954d7e2b93d22fb774bb7b9fe65cf5c65df4c2e3
container_end_page 461
container_issue 4
container_start_page 454
container_title Acta ophthalmologica (Oxford, England)
container_volume 100
creator Minderhout, Helena M.
Joosse, Maurits V.
Grootendorst, Diana C.
Schalij‐Delfos, Nicoline E.
description Purpose To compare the refractive outcome and residual accommodation with respect to various degrees of iris and skin pigmentation in hypermetropic children using 2 drops of cyclopentolate 1% (C + C) or 1 drop of cyclopentolate 1% and 1 drop of tropicamide 1% (C + T). Methods Two hundred fifty‐one hypermetropic children were classified according to iris and skin pigmentation (light, medium, dark) and received randomized and double‐blind C + C or C + T. Refractive error (spherical equivalent, SEQ) was determined using the Retinomax‐K + 3. In 204 subjects, residual accommodation (RA) was determined using the PlusoptiX PowerRefractor. Results A linear mixed model with a light‐irided and light skin‐pigmented reference group receiving C + T (mean SEQ +3.10 ± 1.87D) indicated significant less hypermetropia in subjects with a dark iris having a medium‐ and dark‐pigmented skin in C + T, −1.02 ± 0.29 (−1.59/−0.45) and −1.53 ± 0.30 (−2.10/−0.95); and in subjects having a light‐, medium‐ and dark‐pigmented skin in C + C, −0.74 ± 0.34 (−1.41/−0.06), −1.26 ± 0.30 (−1.85/−0.66) and −1.84 ± 0.30 (−2.42/−1.26). Similar findings were present for RA. Our model with a light‐irided and light skin‐pigmented reference group receiving C + T (mean RA +0.84 ± 0.61D) indicated significantly higher RA in dark‐irided subjects with medium‐ and dark‐pigmented skin in C + T, +1.05 ± 0.19 (+0.67/+1.43) and +1.35 ± 0.20 (+0.9/+1.74), and in C + C, +1.13 ± 0.21 (+0.71/+1.55) and +1.90 ± 0.19 (+1.51/+2.28). Conclusions We found solid evidence that skin pigmentation rather than iris pigmentation is the decisive factor for effectiveness of cycloplegics. Awareness of the limitations of cycloplegic regimens in dark‐irided/pigmented children is needed. Our study showed that cyclopentolate 1% combined with tropicamide 1% provides more accurate refractive outcomes both statistically and clinically integrating the factor skin pigmentation for dark‐irided subjects.
doi_str_mv 10.1111/aos.15016
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9298034</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2660799533</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4436-9b0f869c35da5b30c65eadafb954d7e2b93d22fb774bb7b9fe65cf5c65df4c2e3</originalsourceid><addsrcrecordid>eNp1kkuL1TAUgIsozkMX_gEJiDAu7kzSNumtC2EYxgcMzEIFdyFNTu7NmCadpB2pP9Ff5fF2vKhgFnl--c4JOUXxjNFThu1MxXzKOGXiQXHIGs5XVSPWD_dz_uWgOMr5hlLBhKgfFwdVLZqSUXpY_Licgejo45SICobkry6QwW16CKMaXQxEZZLdJjjrtAojsUqPMWViYyIJbMKluwMSp1HHHnaOBNmZSXmiNO710SwiFG_nAVIPY4qD00RvnTcJwmuiSMKLsXffwRDtXcBYnozJYT9lFzZEz9rHAZOKXo1A2MtdpEWkemdw60nxyCqf4en9eFx8fnv56eL96ur63YeL86uVrutKrNqO2rVodcWN4l1FteCgjLJdy2vTQNm1lSlL2zVN3XVN11oQXFuOmLG1LqE6Lt4s3mHqejAak0rKyyG5XqVZRuXk3yfBbeUm3sm2bNe0qlFwci9I8XaCPMreZQ3eqwBxyrLka14zxlmD6It_0Bv8qYDPk6UQtGlbXlVIvVoonWLO-Cv7ZBiVvypEYoXIXYUg-_zP7Pfk75JA4GwBvjkP8_9N8vz646L8CTmlzKU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2660799533</pqid></control><display><type>article</type><title>Eye colour and skin pigmentation as significant factors for refractive outcome and residual accommodation in hypermetropic children: a randomized clinical trial using cyclopentolate 1% and tropicamide 1</title><source>Wiley</source><creator>Minderhout, Helena M. ; Joosse, Maurits V. ; Grootendorst, Diana C. ; Schalij‐Delfos, Nicoline E.</creator><creatorcontrib>Minderhout, Helena M. ; Joosse, Maurits V. ; Grootendorst, Diana C. ; Schalij‐Delfos, Nicoline E.</creatorcontrib><description>Purpose To compare the refractive outcome and residual accommodation with respect to various degrees of iris and skin pigmentation in hypermetropic children using 2 drops of cyclopentolate 1% (C + C) or 1 drop of cyclopentolate 1% and 1 drop of tropicamide 1% (C + T). Methods Two hundred fifty‐one hypermetropic children were classified according to iris and skin pigmentation (light, medium, dark) and received randomized and double‐blind C + C or C + T. Refractive error (spherical equivalent, SEQ) was determined using the Retinomax‐K + 3. In 204 subjects, residual accommodation (RA) was determined using the PlusoptiX PowerRefractor. Results A linear mixed model with a light‐irided and light skin‐pigmented reference group receiving C + T (mean SEQ +3.10 ± 1.87D) indicated significant less hypermetropia in subjects with a dark iris having a medium‐ and dark‐pigmented skin in C + T, −1.02 ± 0.29 (−1.59/−0.45) and −1.53 ± 0.30 (−2.10/−0.95); and in subjects having a light‐, medium‐ and dark‐pigmented skin in C + C, −0.74 ± 0.34 (−1.41/−0.06), −1.26 ± 0.30 (−1.85/−0.66) and −1.84 ± 0.30 (−2.42/−1.26). Similar findings were present for RA. Our model with a light‐irided and light skin‐pigmented reference group receiving C + T (mean RA +0.84 ± 0.61D) indicated significantly higher RA in dark‐irided subjects with medium‐ and dark‐pigmented skin in C + T, +1.05 ± 0.19 (+0.67/+1.43) and +1.35 ± 0.20 (+0.9/+1.74), and in C + C, +1.13 ± 0.21 (+0.71/+1.55) and +1.90 ± 0.19 (+1.51/+2.28). Conclusions We found solid evidence that skin pigmentation rather than iris pigmentation is the decisive factor for effectiveness of cycloplegics. Awareness of the limitations of cycloplegic regimens in dark‐irided/pigmented children is needed. Our study showed that cyclopentolate 1% combined with tropicamide 1% provides more accurate refractive outcomes both statistically and clinically integrating the factor skin pigmentation for dark‐irided subjects.</description><identifier>ISSN: 1755-375X</identifier><identifier>EISSN: 1755-3768</identifier><identifier>DOI: 10.1111/aos.15016</identifier><identifier>PMID: 34672100</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Children ; cyclopentolate ; cycloplegics ; dark iris ; hypermetropia ; Iris ; Original ; pigmentation ; residual accommodation ; Skin ; Skin pigmentation</subject><ispartof>Acta ophthalmologica (Oxford, England), 2022-06, Vol.100 (4), p.454-461</ispartof><rights>2021 The Authors. Acta Ophthalmologica published by John Wiley &amp; Sons Ltd on behalf of Foundation</rights><rights>2021 The Authors. Acta Ophthalmologica published by John Wiley &amp; Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation.</rights><rights>2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4436-9b0f869c35da5b30c65eadafb954d7e2b93d22fb774bb7b9fe65cf5c65df4c2e3</citedby><cites>FETCH-LOGICAL-c4436-9b0f869c35da5b30c65eadafb954d7e2b93d22fb774bb7b9fe65cf5c65df4c2e3</cites><orcidid>0000-0002-0154-8815</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34672100$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Minderhout, Helena M.</creatorcontrib><creatorcontrib>Joosse, Maurits V.</creatorcontrib><creatorcontrib>Grootendorst, Diana C.</creatorcontrib><creatorcontrib>Schalij‐Delfos, Nicoline E.</creatorcontrib><title>Eye colour and skin pigmentation as significant factors for refractive outcome and residual accommodation in hypermetropic children: a randomized clinical trial using cyclopentolate 1% and tropicamide 1</title><title>Acta ophthalmologica (Oxford, England)</title><addtitle>Acta Ophthalmol</addtitle><description>Purpose To compare the refractive outcome and residual accommodation with respect to various degrees of iris and skin pigmentation in hypermetropic children using 2 drops of cyclopentolate 1% (C + C) or 1 drop of cyclopentolate 1% and 1 drop of tropicamide 1% (C + T). Methods Two hundred fifty‐one hypermetropic children were classified according to iris and skin pigmentation (light, medium, dark) and received randomized and double‐blind C + C or C + T. Refractive error (spherical equivalent, SEQ) was determined using the Retinomax‐K + 3. In 204 subjects, residual accommodation (RA) was determined using the PlusoptiX PowerRefractor. Results A linear mixed model with a light‐irided and light skin‐pigmented reference group receiving C + T (mean SEQ +3.10 ± 1.87D) indicated significant less hypermetropia in subjects with a dark iris having a medium‐ and dark‐pigmented skin in C + T, −1.02 ± 0.29 (−1.59/−0.45) and −1.53 ± 0.30 (−2.10/−0.95); and in subjects having a light‐, medium‐ and dark‐pigmented skin in C + C, −0.74 ± 0.34 (−1.41/−0.06), −1.26 ± 0.30 (−1.85/−0.66) and −1.84 ± 0.30 (−2.42/−1.26). Similar findings were present for RA. Our model with a light‐irided and light skin‐pigmented reference group receiving C + T (mean RA +0.84 ± 0.61D) indicated significantly higher RA in dark‐irided subjects with medium‐ and dark‐pigmented skin in C + T, +1.05 ± 0.19 (+0.67/+1.43) and +1.35 ± 0.20 (+0.9/+1.74), and in C + C, +1.13 ± 0.21 (+0.71/+1.55) and +1.90 ± 0.19 (+1.51/+2.28). Conclusions We found solid evidence that skin pigmentation rather than iris pigmentation is the decisive factor for effectiveness of cycloplegics. Awareness of the limitations of cycloplegic regimens in dark‐irided/pigmented children is needed. Our study showed that cyclopentolate 1% combined with tropicamide 1% provides more accurate refractive outcomes both statistically and clinically integrating the factor skin pigmentation for dark‐irided subjects.</description><subject>Children</subject><subject>cyclopentolate</subject><subject>cycloplegics</subject><subject>dark iris</subject><subject>hypermetropia</subject><subject>Iris</subject><subject>Original</subject><subject>pigmentation</subject><subject>residual accommodation</subject><subject>Skin</subject><subject>Skin pigmentation</subject><issn>1755-375X</issn><issn>1755-3768</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp1kkuL1TAUgIsozkMX_gEJiDAu7kzSNumtC2EYxgcMzEIFdyFNTu7NmCadpB2pP9Ff5fF2vKhgFnl--c4JOUXxjNFThu1MxXzKOGXiQXHIGs5XVSPWD_dz_uWgOMr5hlLBhKgfFwdVLZqSUXpY_Licgejo45SICobkry6QwW16CKMaXQxEZZLdJjjrtAojsUqPMWViYyIJbMKluwMSp1HHHnaOBNmZSXmiNO710SwiFG_nAVIPY4qD00RvnTcJwmuiSMKLsXffwRDtXcBYnozJYT9lFzZEz9rHAZOKXo1A2MtdpEWkemdw60nxyCqf4en9eFx8fnv56eL96ur63YeL86uVrutKrNqO2rVodcWN4l1FteCgjLJdy2vTQNm1lSlL2zVN3XVN11oQXFuOmLG1LqE6Lt4s3mHqejAak0rKyyG5XqVZRuXk3yfBbeUm3sm2bNe0qlFwci9I8XaCPMreZQ3eqwBxyrLka14zxlmD6It_0Bv8qYDPk6UQtGlbXlVIvVoonWLO-Cv7ZBiVvypEYoXIXYUg-_zP7Pfk75JA4GwBvjkP8_9N8vz646L8CTmlzKU</recordid><startdate>202206</startdate><enddate>202206</enddate><creator>Minderhout, Helena M.</creator><creator>Joosse, Maurits V.</creator><creator>Grootendorst, Diana C.</creator><creator>Schalij‐Delfos, Nicoline E.</creator><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0154-8815</orcidid></search><sort><creationdate>202206</creationdate><title>Eye colour and skin pigmentation as significant factors for refractive outcome and residual accommodation in hypermetropic children: a randomized clinical trial using cyclopentolate 1% and tropicamide 1</title><author>Minderhout, Helena M. ; Joosse, Maurits V. ; Grootendorst, Diana C. ; Schalij‐Delfos, Nicoline E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4436-9b0f869c35da5b30c65eadafb954d7e2b93d22fb774bb7b9fe65cf5c65df4c2e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Children</topic><topic>cyclopentolate</topic><topic>cycloplegics</topic><topic>dark iris</topic><topic>hypermetropia</topic><topic>Iris</topic><topic>Original</topic><topic>pigmentation</topic><topic>residual accommodation</topic><topic>Skin</topic><topic>Skin pigmentation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Minderhout, Helena M.</creatorcontrib><creatorcontrib>Joosse, Maurits V.</creatorcontrib><creatorcontrib>Grootendorst, Diana C.</creatorcontrib><creatorcontrib>Schalij‐Delfos, Nicoline E.</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Free Content</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Acta ophthalmologica (Oxford, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Minderhout, Helena M.</au><au>Joosse, Maurits V.</au><au>Grootendorst, Diana C.</au><au>Schalij‐Delfos, Nicoline E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Eye colour and skin pigmentation as significant factors for refractive outcome and residual accommodation in hypermetropic children: a randomized clinical trial using cyclopentolate 1% and tropicamide 1</atitle><jtitle>Acta ophthalmologica (Oxford, England)</jtitle><addtitle>Acta Ophthalmol</addtitle><date>2022-06</date><risdate>2022</risdate><volume>100</volume><issue>4</issue><spage>454</spage><epage>461</epage><pages>454-461</pages><issn>1755-375X</issn><eissn>1755-3768</eissn><abstract>Purpose To compare the refractive outcome and residual accommodation with respect to various degrees of iris and skin pigmentation in hypermetropic children using 2 drops of cyclopentolate 1% (C + C) or 1 drop of cyclopentolate 1% and 1 drop of tropicamide 1% (C + T). Methods Two hundred fifty‐one hypermetropic children were classified according to iris and skin pigmentation (light, medium, dark) and received randomized and double‐blind C + C or C + T. Refractive error (spherical equivalent, SEQ) was determined using the Retinomax‐K + 3. In 204 subjects, residual accommodation (RA) was determined using the PlusoptiX PowerRefractor. Results A linear mixed model with a light‐irided and light skin‐pigmented reference group receiving C + T (mean SEQ +3.10 ± 1.87D) indicated significant less hypermetropia in subjects with a dark iris having a medium‐ and dark‐pigmented skin in C + T, −1.02 ± 0.29 (−1.59/−0.45) and −1.53 ± 0.30 (−2.10/−0.95); and in subjects having a light‐, medium‐ and dark‐pigmented skin in C + C, −0.74 ± 0.34 (−1.41/−0.06), −1.26 ± 0.30 (−1.85/−0.66) and −1.84 ± 0.30 (−2.42/−1.26). Similar findings were present for RA. Our model with a light‐irided and light skin‐pigmented reference group receiving C + T (mean RA +0.84 ± 0.61D) indicated significantly higher RA in dark‐irided subjects with medium‐ and dark‐pigmented skin in C + T, +1.05 ± 0.19 (+0.67/+1.43) and +1.35 ± 0.20 (+0.9/+1.74), and in C + C, +1.13 ± 0.21 (+0.71/+1.55) and +1.90 ± 0.19 (+1.51/+2.28). Conclusions We found solid evidence that skin pigmentation rather than iris pigmentation is the decisive factor for effectiveness of cycloplegics. Awareness of the limitations of cycloplegic regimens in dark‐irided/pigmented children is needed. Our study showed that cyclopentolate 1% combined with tropicamide 1% provides more accurate refractive outcomes both statistically and clinically integrating the factor skin pigmentation for dark‐irided subjects.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>34672100</pmid><doi>10.1111/aos.15016</doi><tpages>461</tpages><orcidid>https://orcid.org/0000-0002-0154-8815</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1755-375X
ispartof Acta ophthalmologica (Oxford, England), 2022-06, Vol.100 (4), p.454-461
issn 1755-375X
1755-3768
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9298034
source Wiley
subjects Children
cyclopentolate
cycloplegics
dark iris
hypermetropia
Iris
Original
pigmentation
residual accommodation
Skin
Skin pigmentation
title Eye colour and skin pigmentation as significant factors for refractive outcome and residual accommodation in hypermetropic children: a randomized clinical trial using cyclopentolate 1% and tropicamide 1
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T15%3A58%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Eye%20colour%20and%20skin%20pigmentation%20as%20significant%20factors%20for%20refractive%20outcome%20and%20residual%20accommodation%20in%20hypermetropic%20children:%20a%20randomized%20clinical%20trial%20using%20cyclopentolate%201%25%20and%20tropicamide%201&rft.jtitle=Acta%20ophthalmologica%20(Oxford,%20England)&rft.au=Minderhout,%20Helena%20M.&rft.date=2022-06&rft.volume=100&rft.issue=4&rft.spage=454&rft.epage=461&rft.pages=454-461&rft.issn=1755-375X&rft.eissn=1755-3768&rft_id=info:doi/10.1111/aos.15016&rft_dat=%3Cproquest_pubme%3E2660799533%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4436-9b0f869c35da5b30c65eadafb954d7e2b93d22fb774bb7b9fe65cf5c65df4c2e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2660799533&rft_id=info:pmid/34672100&rfr_iscdi=true